Global Intensive Care Unit (ICU) Equipment Market By Type (Mechanical Ventilators, Cardiac Monitors, Equipment for The Constant Monitoring, Feeding Tubes, Nasogastric Tubes, Suction Pumps, and Drains and Catheters), By Application (Hospitals, and Ambulatory Surgical Center), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

Published date: Jul 2022
Report ID: 49765
Number of Pages: 256
Format:

- 1. Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Overview
  - 3.1. Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Dynamics
    3.1.1. Drivers
    3.1.2. Opportunities
    3.1.3. Restraints
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Production Analysis by Region/Company
  - 3.9. Industry chain Analysis
  - 3.10. Marketing Strategy
- 4. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Mechanical Ventilators
  - 4.4. Cardiac Monitors
  - 4.5. Equipment for The Constant Monitoring
  - 4.6. Feeding Tubes
  - 4.7. Nasogastric Tubes
  - 4.8. Suction Pumps
  - 4.9. Drains and Catheters
- 5. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Hospitals
  - 5.4. Ambulatory Surgical Center
- 6. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    6.1.1. North America Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market: Regional Trend Analysis
    6.1.1.1. US
    6.1.1.2. Canada
    6.1.1.3. Mexico
  - 6.2.1. Europe
    6.2.1. Europe Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market: Regional Trend Analysis
    6.2.1.1. Germany
    6.2.1.2. France
    6.2.1.3. UK
    6.2.1.4. Russia
    6.2.1.5. Italy
    6.2.1.6. Spain
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    6.3.1. Asia-Pacific Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market: Regional Trend Analysis
    6.3.1.1. China
    6.3.1.2. Japan
    6.3.1.3. Korea
    6.3.1.4. India
    6.3.1.5. Rest of Asia-Pacific
  - 6.4. Latin America
    6.4.1. Latin America Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market: Regional Trend Analysis
    6.4.1.1. Brazil
    6.4.1.2. Argentina
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    6.5.1. Middle East and Africa Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market: Regional Trend Analysis
    6.5.1.1. GCC
    6.5.1.2. South Africa
    6.5.1.3. Israel
    6.5.1.4. Rest of MEA
- 7. Global Intensive Care (US$ Mn & '000 Units) (ICU) Equipment Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Johnson & Johnson
    7.3.1. Company Overview
    7.3.2. Financial Highlights
    7.3.3. Product Portfolio
    7.3.4. SWOT Analysis
    7.3.5. Key Strategies and Developments
  - 7.4. GE Healthcare
    7.4.1. Company Overview
    7.4.2. Financial Highlights
    7.4.3. Product Portfolio
    7.4.4. SWOT Analysis
    7.4.5. Key Strategies and Developments
  - 7.5. Siemens
    7.5.1. Company Overview
    7.5.2. Financial Highlights
    7.5.3. Product Portfolio
    7.5.4. SWOT Analysis
    7.5.5. Key Strategies and Developments
  - 7.6. Bayer AG
    7.6.1. Company Overview
    7.6.2. Financial Highlights
    7.6.3. Product Portfolio
    7.6.4. SWOT Analysis
    7.6.5. Key Strategies and Developments
  - 7.7. Medtronic
    7.7.1. Company Overview
    7.7.2. Financial Highlights
    7.7.3. Product Portfolio
    7.7.4. SWOT Analysis
    7.7.5. Key Strategies and Developments
  - 7.8. Baxter International Inc
    7.8.1. Company Overview
    7.8.2. Financial Highlights
    7.8.3. Product Portfolio
    7.8.4. SWOT Analysis
    7.8.5. Key Strategies and Developments
  - 7.9. Fresenius Medical Care
    7.9.1. Company Overview
    7.9.2. Financial Highlights
    7.9.3. Product Portfolio
    7.9.4. SWOT Analysis
    7.9.5. Key Strategies and Developments
  - 7.10. Covidien plc
    7.10.1. Company Overview
    7.10.2. Financial Highlights
    7.10.3. Product Portfolio
    7.10.4. SWOT Analysis
    7.10.5. Key Strategies and Developments
  - 7.11. Novartis AG
    7.11.1. Company Overview
    7.11.2. Financial Highlights
    7.11.3. Product Portfolio
    7.11.4. SWOT Analysis
    7.11.5. Key Strategies and Developments
  - 7.12. Cardinal Health Inc
    7.12.1. Company Overview
    7.12.2. Financial Highlights
    7.12.3. Product Portfolio
    7.12.4. SWOT Analysis
    7.12.5. Key Strategies and Developments
  - 7.13. Stryker Corp.
    7.13.1. Company Overview
    7.13.2. Financial Highlights
    7.13.3. Product Portfolio
    7.13.4. SWOT Analysis
    7.13.5. Key Strategies and Developments
  - 7.14. Allergan Inc.
    7.14.1. Company Overview
    7.14.2. Financial Highlights
    7.14.3. Product Portfolio
    7.14.4. SWOT Analysis
    7.14.5. Key Strategies and Developments
  - 7.15. 3M
    7.15.1. Company Overview
    7.15.2. Financial Highlights
    7.15.3. Product Portfolio
    7.15.4. SWOT Analysis
    7.15.5. Key Strategies and Developments
  - 7.16. Terumo Corp.
    7.16.1. Company Overview
    7.16.2. Financial Highlights
    7.16.3. Product Portfolio
    7.16.4. SWOT Analysis
    7.16.5. Key Strategies and Developments
  - 7.17. Olympus Corp.
    7.17.1. Company Overview
    7.17.2. Financial Highlights
    7.17.3. Product Portfolio
    7.17.4. SWOT Analysis
    7.17.5. Key Strategies and Developments
  - 7.18. Toshiba Corp.
    7.18.1. Company Overview
    7.18.2. Financial Highlights
    7.18.3. Product Portfolio
    7.18.4. SWOT Analysis
    7.18.5. Key Strategies and Developments
  - 7.19. CR Bard Inc.
    7.19.1. Company Overview
    7.19.2. Financial Highlights
    7.19.3. Product Portfolio
    7.19.4. SWOT Analysis
    7.19.5. Key Strategies and Developments
  - 7.20. Hologic Inc.
    7.20.1. Company Overview
    7.20.2. Financial Highlights
    7.20.3. Product Portfolio
    7.20.4. SWOT Analysis
    7.20.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Johnson & Johnson
- GE Healthcare
- Siemens Aktiengesellschaft Company Profile
- Bayer AG Company Profile
- Medtronic
- Baxter International Inc Company Profile
- Fresenius Medical Care
- Covidien plc
- Novartis AG Company Profile
- Cardinal Health Inc
- Stryker Corp.
- Allergan Inc.
- 3M Company Company Profile
- Terumo Corp.
- Olympus Corp.
- Toshiba Corp.
- CR Bard Inc.
- Hologic Inc.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)